Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can better Doctor-Patient talks improve rheumatoid arthritis care?

NCT ID NCT05530694

Knowledge-focused Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study tested whether training rheumatology clinicians in shared decision making helps veterans with rheumatoid arthritis. About 900 patients from VA clinics took part. The training taught doctors to acknowledge treatment options and involve patients in choices. Researchers measured disease activity, medication adherence, and patient knowledge to see if this approach improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
clinician communication training (fostering choice awareness)
What this could lead to
If successful, this approach could help doctors and patients work together better, potentially improving disease control and reducing health disparities in rheumatoid arthritis care.
What could go wrong
This is a behavioral intervention study, not a drug trial, so any benefits are likely modest. Results may not apply outside the VA system or to patients with mild disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

900 people

The number who actually took part.

Started

Sep 2022

Finished

Feb 2026

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Inclusion criteria for patient participants (Aims 1 \& 2): * Meet administrative data definition of rheumatoid arthritis (see recruitment section) * Receive rheumatology outpatient care at participating clinics and seen at least once in prior 12 months * Age 18 years or older * English speaking * Moderate to high RA disease activity within 18 months prior to enrollment Inclusion criteria for professional participants (Aims 1-3): -Rheumatology attendings, fellows or advanced practice partners (nurse practitioners or physicians assistants) at the respective clinics Inclusion criteria for non-clinician participants (Aim 3): * Have held a leadership position within their respective institution for minimum of 12 months prior to enrollment * Have worked in the rheumatology clinic setting at their respective institution for minimum of 12 months prior Exclusion Criteria: Exclusion criteria for patient participants (Aims 1 \& 2): * Cognitive impairment * Inability to speak Exclusion criteria for professional participants (Aims 1-3): -none Exclusion criteria for non-clinician participants (Aim 3): * Have held a leadership position within their respective institution for \<12 months * Have worked in a clinic setting other than rheumatology * Have worked in a clinic setting \<12 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rheumatoid arthritis

Contacts and locations

Locations

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia, Pennsylvania, 19104, United States

  • San Francisco VA Medical Center, San Francisco, CA

    San Francisco, California, 94121, United States

  • VA Portland Health Care System, Portland, OR

    Portland, Oregon, 97207-2964, United States

  • Wilmington VA Medical Center, Wilmington, DE

    Wilmington, Delaware, 19805-4917, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.